Drug establishmentActive, Registered FY2026FDA warning letter on file
Intas Pharmaceuticals Limited
Intas Pharmaceuticals Limited is an FDA-registered drug establishment (FEI 3004011473) located in . The facility is active, registered for FY2026. FDA has issued 1 warning letter(s) to this facility.
FDA warning letter
A warning letter is FDA's formal notice of significant violations that require prompt correction. It can hold up product approvals, trigger import alerts, and put supply agreements at risk until the issues are resolved and FDA closes it out.
Establishment record
Inspection history
FDA publishes only a subset of inspection records and Form 483s, so "None on file" is not a guarantee of a clean inspection history.
Questions
Is Intas Pharmaceuticals Limited registered with the FDA?
Yes. Intas Pharmaceuticals Limited is an FDA-registered drug establishment (FEI 3004011473) in . Its current registration status is Active, Registered FY2026.
Has Intas Pharmaceuticals Limited received an FDA warning letter?
Yes. FDA issued a warning letter to Intas Pharmaceuticals Limited; the most recent is dated Mar 30, 2026 (CGMP/Finished Pharmaceuticals/Adulterated).
What does Intas Pharmaceuticals Limited do?
Intas Pharmaceuticals Limited's FDA-registered operations are: ANALYSIS; MANUFACTURE; PACK.
Related facilities
Source: FDA public data · status as of 2026-06-01